Childhood and teen obesity rates have soared to record highs with about 1 in 5 living with obesity. The FDA has approved GLP-1 drugs for weight loss among kids 12 and older. Dr. Rachel Pessah-Pollack explains the risks and benefits, who may be a candidate and more.
Childhood and teen obesity rates have soared to record highs with about 1 in 5 living with obesity. The FDA has approved GLP-1 drugs for weight loss among kids 12 and older. Dr. Rachel Pessah-Pollack explains the risks and benefits, who may be a candidate and more.
<iframe src="https://statesidedaily.com/embed/cluster/dfc6f15590a43270b65f1e9b39e306f522e875cd" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Weighing the risks and benefits of GLP-1 drugs for kids struggling with obesity"></iframe>
